Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent

AAPS PharmSciTech

Volumn 11, Issue 2, 2010, Pages 528-537

  Kaur, Navjot ^a   Puri, Richa ^a   Jain, Subheet Kumar ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Cyclodextrin vesicles dual approach, skin irritation; Elastic liposomes; Isotretinoin; Skin targeting

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DRUG CARRIER; ISOTRETINOIN; LIPOSOME; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; DERMATOLOGICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHOTODEGRADATION; PRIORITY JOURNAL; RAT; SKIN IRRITATION; SKIN PERMEABILITY; SKIN TOXICITY; ACNE VULGARIS; ANIMAL; CHEMISTRY; HUMAN; PROCEDURES; SKIN; SKIN ABSORPTION; SYNTHESIS; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANIMALS; BETA-CYCLODEXTRINS; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; RATS; SKIN; SKIN ABSORPTION; UNILAMELLAR LIPOSOMES; IN VITRO TECHNIQUES;

EID: 77954819488     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9411-2     Document Type: Article

References (34)

1. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs. 1984;28:6-37. (Pubitemid 14112379)
2. Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H et al. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). J Clin Oncol. 2005;23:4172-78.
3. McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol. 2001;45:S187-94.
4. Gollnick H, Ehlert R, Rinck G, Orfanos CE. Retinoids: an overview of pharmacokinetics and therapeutic value. Methods Enzymol. 1990;190:291-304.
5. Peinni C, Vigolti M. Drug and cosmetics in relation to the topical treatment of acne: data from a nationwide enquiry. Cosmet Dermatol. 1991;2:17-26.
6. Layton AM, Cunlife WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol. 1992;27:S2-7.
7. Elbaum DJ. Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol. 1988;19:486-91.
8. Lehman PA, John JT, Franz TJ. Percutaneous absorption of retinoids: influence of vehicle, light exposure and dose. J Invest Dermatol. 1990;91:56-61.
9. Masini V, Bonte F, Meybeck A, Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J Pharm Sci. 1990;82:17-21.
10. Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carrier for tretinoin I. Preparation and properties. Int J Pharm. 2002;234:237-48.
11. Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticle (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 2007;345:163-71.
12. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013-26.
13. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv. 2005;2:223-33.
14. Garg T, Jain S, Singh HP, Sharma S, Tiwary AK. Elastic liposomal formulation for sustained delivery of anti-migraine drug: In vitro characterization and biological evaluation. Drug Dev Ind Pharm. 2008;34(10):1100-10.
15. Singh HP, Utreja P, Tiwary AK, Jain S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J. 2009;11(1):54-64.
16. Cal K, Centkowska K. Use of cyclodextrins in topical formulations: practical aspects. Eur J Pharm Biopharm. 2008;68:467-78.
17. Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm. 2006;312:53-60.
18. Yap KL, Liu X, Thenmozhiyal JC, Ho PC. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexs by phase solubility, photostability, physicochemical and computational analysis. Eur J Pharm Sci. 2005;25:49-56.
19. Cevc G, Blume G, Schatzlein A. Transfersomes mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211-26.
20. Tashtoush BM, Jacobson EL, Jacobson MK. A rapid HPLC method for simultaneous determination of tretinoin and isotretinoin in dermatological formulations. J Pharm Biomed Anal. 2007;43:859-64.
21. Draize JH, Woodward G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;8:377-90.
22. Kaur K, Jain S, Sapra B, Tiwary AK. Niosomal gel for site specific sustained delivery of anti-arthritic drug: in vitro in vivo evaluation. Curr Drug Deliv. 2007;4(4):276-82.
23. El Maghraby G M M, Williams AC, Barry BW. Skin delivery from ultradeformable liposomes: refinement of surfactant concentration. J Pharm Pharmacol. 1999;51:1123-34.
24. Jain S, Tiwary AK, Jain NK. Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr Drug Deliv. 2006;3(2):157-66.
25. Williams AC, Shatri SR, Barry BW. Transdermal permeation modulation by cyclodextrins: a mechanistic study. Pharm Dev Technol. 1998;3:283-96.
26. Rowe RC, Sheskey PJ, Owen SC (2006) Handbook of pharmaceutical excipients, 5th ed., American Pharmaceutical Association. 217-21.
27. Caddeo C, Manconi M, Valenti D, Pini E, Sinico C. Photostability and solubility improvement of β-cyclodextrin-included tretinoin. J Incl Phenom Macrocycl Chem. 2007;59:293-300.
28. Montassier P, Duchene D, Poieman MC. Inclusion complex of tretinoin with cyclodextrins. Int J Pharm. 1997;153:199-209.
29. Dalmora ME, Dalmora SL, Oliveira AG. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical antiinflammatory effect. Int J Pharm. 2001;222:45-55.
30. Dromgoole SH, Maibach HI. Sunscreening agent intolerance: contact and photocontact sensitization and contact urticaria. J Am Acad Dermatol. 1990;22:1068-78.
31. Tan X, Meltzer N, Lindenbaum S. Determination of the kinetics of degradation of 13-cis retinoic acid and all-trans retinoic acid in solution. J Pharm Biomed Anal. 1993;11:817-22.
32. Code of Federal Regulation (1976) Title 16, Part 173.210.
33. Yamaguchi Y, Nagasawa T, Nakamura N, Takenaga M, Mizoguchi M, Kawai S et al. Successful treatment of photo-damaged skin of nano-scale at RA particles using a novel transdermal delivery. J Control Release. 2005;104:29-40.
34. Campbell KI, George EL, Hall LL, Stara JF. Dermal irritancy of metal compounds. Studies with palladium, platinum, lead, and manganese compounds. Arch Enviorn Health. 1975;30:168-70.